retinal rods
Recently Published Documents


TOTAL DOCUMENTS

233
(FIVE YEARS 9)

H-INDEX

60
(FIVE YEARS 2)

Author(s):  
Diane C. A. Barret ◽  
Gebhard F. X. Schertler ◽  
U. Benjamin Kaupp ◽  
Jacopo Marino
Keyword(s):  

2021 ◽  
Vol 22 (16) ◽  
pp. 8731
Author(s):  
James B. Ames

Retinal guanylate cyclases (RetGCs) promote the Ca2+-dependent synthesis of cGMP that coordinates the recovery phase of visual phototransduction in retinal rods and cones. The Ca2+-sensitive activation of RetGCs is controlled by a family of photoreceptor Ca2+ binding proteins known as guanylate cyclase activator proteins (GCAPs). The Mg2+-bound/Ca2+-free GCAPs bind to RetGCs and activate cGMP synthesis (cyclase activity) at low cytosolic Ca2+ levels in light-activated photoreceptors. By contrast, Ca2+-bound GCAPs bind to RetGCs and inactivate cyclase activity at high cytosolic Ca2+ levels found in dark-adapted photoreceptors. Mutations in both RetGCs and GCAPs that disrupt the Ca2+-dependent cyclase activity are genetically linked to various retinal diseases known as cone-rod dystrophies. In this review, I will provide an overview of the known atomic-level structures of various GCAP proteins to understand how protein dimerization and Ca2+-dependent conformational changes in GCAPs control the cyclase activity of RetGCs. This review will also summarize recent structural studies on a GCAP homolog from zebrafish (GCAP5) that binds to Fe2+ and may serve as a Fe2+ sensor in photoreceptors. The GCAP structures reveal an exposed hydrophobic surface that controls both GCAP1 dimerization and RetGC binding. This exposed site could be targeted by therapeutics designed to inhibit the GCAP1 disease mutants, which may serve to mitigate the onset of retinal cone-rod dystrophies.


2021 ◽  
Vol 141 (3) ◽  
pp. 402-407
Author(s):  
Akane Yamashita ◽  
Yoshimi Kamiyama

2020 ◽  
Vol 51 (1) ◽  
pp. 116-122
Author(s):  
A. Yu. Rotov ◽  
L. A. Astakhova ◽  
M. L. Firsov ◽  
V. I. Govardovskii

PLoS ONE ◽  
2019 ◽  
Vol 14 (12) ◽  
pp. e0225948 ◽  
Author(s):  
Giovanni Caruso ◽  
Vsevolod V. Gurevich ◽  
Colin Klaus ◽  
Heidi Hamm ◽  
Clint L. Makino ◽  
...  

2019 ◽  
Vol 151 (7) ◽  
pp. 875-877
Author(s):  
Edward N. Pugh

Pugh highlights recent work ruling out a role for ultraweak photon emission in spontaneous photon-like events in retinal rods.


2019 ◽  
Vol 116 (18) ◽  
pp. 8653-8654 ◽  
Author(s):  
Martin Heck ◽  
Klaus Peter Hofmann ◽  
Timothy W. Kraft ◽  
Trevor D. Lamb

2019 ◽  
Vol 116 (11) ◽  
pp. 5144-5153 ◽  
Author(s):  
Wendy W. S. Yue ◽  
Daniel Silverman ◽  
Xiaozhi Ren ◽  
Rikard Frederiksen ◽  
Kazumi Sakai ◽  
...  

G protein-coupled receptor (GPCR) signaling is crucial for many physiological processes. A signature of such pathways is high amplification, a concept originating from retinal rod phototransduction, whereby one photoactivated rhodopsin molecule (Rho*) was long reported to activate several hundred transducins (GT*s), each then activating a cGMP-phosphodiesterase catalytic subunit (GT*·PDE*). This high gain at the Rho*-to-GT* step has been challenged more recently, but estimates remain dispersed and rely on some nonintact rod measurements. With two independent approaches, one with an extremely inefficient mutant rhodopsin and the other with WT bleached rhodopsin, which has exceedingly weak constitutive activity in darkness, we obtained an estimate for the electrical effect from a single GT*·PDE* molecular complex in intact mouse rods. Comparing the single-GT*·PDE* effect to the WT single-photon response, both in Gcaps−/− background, gives an effective gain of only ∼12–14 GT*·PDE*s produced per Rho*. Our findings have finally dispelled the entrenched concept of very high gain at the receptor-to-G protein/effector step in GPCR systems.


eNeuro ◽  
2019 ◽  
Vol 6 (1) ◽  
pp. ENEURO.0393-18.2019
Author(s):  
Clint L. Makino ◽  
Teresa Duda ◽  
Alexandre Pertzev ◽  
Tomoki Isayama ◽  
Polina Geva ◽  
...  

Open Biology ◽  
2018 ◽  
Vol 8 (8) ◽  
pp. 180075 ◽  
Author(s):  
Bilal M. Qureshi ◽  
Elmar Behrmann ◽  
Johannes Schöneberg ◽  
Justus Loerke ◽  
Jörg Bürger ◽  
...  

Among cyclic nucleotide phosphodiesterases (PDEs), PDE6 is unique in serving as an effector enzyme in G protein-coupled signal transduction. In retinal rods and cones, PDE6 is membrane-bound and activated to hydrolyse its substrate, cGMP, by binding of two active G protein α-subunits (Gα*). To investigate the activation mechanism of mammalian rod PDE6, we have collected functional and structural data, and analysed them by reaction–diffusion simulations. Gα* titration of membrane-bound PDE6 reveals a strong functional asymmetry of the enzyme with respect to the affinity of Gα* for its two binding sites on membrane-bound PDE6 and the enzymatic activity of the intermediary 1 : 1 Gα* · PDE6 complex. Employing cGMP and its 8-bromo analogue as substrates, we find that Gα* · PDE6 forms with high affinity but has virtually no cGMP hydrolytic activity. To fully activate PDE6, it takes a second copy of Gα* which binds with lower affinity, forming Gα* · PDE6 · Gα*. Reaction–diffusion simulations show that the functional asymmetry of membrane-bound PDE6 constitutes a coincidence switch and explains the lack of G protein-related noise in visual signal transduction. The high local concentration of Gα* generated by a light-activated rhodopsin molecule efficiently activates PDE6, whereas the low density of spontaneously activated Gα* fails to activate the effector enzyme.


Sign in / Sign up

Export Citation Format

Share Document